Effects of zoledronate on bone mineral density and bone turnover after long-term denosumab therapy: Observations in a real-world setting
Judith Everts‐Graber, Stephan Reichenbach, Brigitta Gahl, HansJörg Häuselmann, Hans‐Rudolf Ziswiler, Ueli Studer, Thomas Lehmann
Topics & Concepts
DenosumabMedicineBone mineralBone remodelingDiscontinuationFemoral neckOsteoporosisUrologyZoledronic acidRegimenInternal medicineBone health and treatmentsBone health and osteoporosis researchBone Metabolism and Diseases